These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

469 related items for PubMed ID: 28320472

  • 1. Increased serum levels of fractalkine and mobilisation of CD34+CD45- endothelial progenitor cells in systemic sclerosis.
    Benyamine A, Magalon J, Cointe S, Lacroix R, Arnaud L, Bardin N, Rossi P, Francès Y, Bernard-Guervilly F, Kaplanski G, Harlé JR, Weiller PJ, Berbis P, Braunstein D, Jouve E, Lesavre N, Couranjou F, Dignat-George F, Sabatier F, Paul P, Granel B.
    Arthritis Res Ther; 2017 Mar 20; 19(1):60. PubMed ID: 28320472
    [Abstract] [Full Text] [Related]

  • 2. Altered serum level of metabolic and endothelial factors in patients with systemic sclerosis.
    Stochmal A, Czuwara J, Zaremba M, Rudnicka L.
    Arch Dermatol Res; 2020 Aug 20; 312(6):453-458. PubMed ID: 31667578
    [Abstract] [Full Text] [Related]

  • 3. Concurrent hypermulticolor monitoring of CD31, CD34, CD45 and CD146 endothelial progenitor cell markers for acute myocardial infarction.
    Shim Y, Nam MH, Hyuk SW, Yoon SY, Song JM.
    Anal Chim Acta; 2015 Jan 01; 853():501-507. PubMed ID: 25467496
    [Abstract] [Full Text] [Related]

  • 4. Up regulated expression of fractalkine/CX3CL1 and CX3CR1 in patients with systemic sclerosis.
    Hasegawa M, Sato S, Echigo T, Hamaguchi Y, Yasui M, Takehara K.
    Ann Rheum Dis; 2005 Jan 01; 64(1):21-8. PubMed ID: 15608300
    [Abstract] [Full Text] [Related]

  • 5. [Systemic sclerosis and scleroderma circumscripta--disturbances of selected serum parameters which are responsible for vascular changes and CD34 expression in involved skin].
    Dziankowska-Bartkowiak B, Zebrowska A, Wagrowska-Danielewicz M, Kobos J, Waszczykowska E.
    Przegl Lek; 2009 Jan 01; 66(12):1040-5. PubMed ID: 20514902
    [Abstract] [Full Text] [Related]

  • 6. Circulating endothelial progenitor cells in systemic sclerosis: association with disease severity.
    Avouac J, Juin F, Wipff J, Couraud PO, Chiocchia G, Kahan A, Boileau C, Uzan G, Allanore Y.
    Ann Rheum Dis; 2008 Oct 01; 67(10):1455-60. PubMed ID: 18174219
    [Abstract] [Full Text] [Related]

  • 7. Plasma endothelial microparticles reflect the extent of capillaroscopic alterations and correlate with the severity of skin involvement in systemic sclerosis.
    Michalska-Jakubus M, Kowal-Bielecka O, Smith V, Cutolo M, Krasowska D.
    Microvasc Res; 2017 Mar 01; 110():24-31. PubMed ID: 27889559
    [Abstract] [Full Text] [Related]

  • 8. Low circulating level of CD133+KDR+cells in patients with systemic sclerosis.
    Mok MY, Yiu KH, Wong CY, Qiuwaxi J, Lai WH, Wong WS, Tse HF, Lau CS.
    Clin Exp Rheumatol; 2010 Mar 01; 28(5 Suppl 62):S19-25. PubMed ID: 21050541
    [Abstract] [Full Text] [Related]

  • 9. Circulating endothelial progenitor cells in systemic sclerosis: relation to impaired angiogenesis and cardiovascular manifestations.
    Nevskaya T, Bykovskaia S, Lyssuk E, Shakhov I, Zaprjagaeva M, Mach E, Ananieva L, Guseva N, Nassonov E.
    Clin Exp Rheumatol; 2008 Mar 01; 26(3):421-9. PubMed ID: 18578963
    [Abstract] [Full Text] [Related]

  • 10. Decreased numbers of endothelial progenitor cells in patients in the early stages of systemic sclerosis.
    Andrigueti FV, Arismendi MI, Ebbing PC, Kayser C.
    Microvasc Res; 2015 Mar 01; 98():82-7. PubMed ID: 25596148
    [Abstract] [Full Text] [Related]

  • 11. Soluble adhesion molecules (sVCAM-1, sE-selectin), vascular endothelial growth factor (VEGF) and endothelin-1 in patients with systemic sclerosis: relationship to organ systemic involvement.
    Kuryliszyn-Moskal A, Klimiuk PA, Sierakowski S.
    Clin Rheumatol; 2005 Apr 01; 24(2):111-6. PubMed ID: 15349798
    [Abstract] [Full Text] [Related]

  • 12. Comparative analysis of methods for assessment of circulating endothelial progenitor cells.
    George J, Shmilovich H, Deutsch V, Miller H, Keren G, Roth A.
    Tissue Eng; 2006 Feb 01; 12(2):331-5. PubMed ID: 16548691
    [Abstract] [Full Text] [Related]

  • 13. Endothelial injury and repair in systemic vasculitis of the young.
    Clarke LA, Hong Y, Eleftheriou D, Shah V, Arrigoni F, Klein NJ, Brogan PA.
    Arthritis Rheum; 2010 Jun 01; 62(6):1770-80. PubMed ID: 20178138
    [Abstract] [Full Text] [Related]

  • 14. Characterization of circulating endothelial microparticles and endothelial progenitor cells in primary Sjögren's syndrome: new markers of chronic endothelial damage?
    Bartoloni E, Alunno A, Bistoni O, Caterbi S, Luccioli F, Santoboni G, Mirabelli G, Cannarile F, Gerli R.
    Rheumatology (Oxford); 2015 Mar 01; 54(3):536-44. PubMed ID: 25190637
    [Abstract] [Full Text] [Related]

  • 15. Elevated Inflammatory Parameter Levels Negatively Impact Populations of Circulating Stem Cells (CD133+), Early Endothelial Progenitor Cells (CD133+/VEGFR2+), and Fibroblast Growth Factor in Stroke Patients.
    Golab-Janowska M, Paczkowska E, Machalinski B, Kotlega D, Meller A, Safranow K, Wankowicz P, Nowacki P.
    Curr Neurovasc Res; 2019 Mar 01; 16(1):19-26. PubMed ID: 30706812
    [Abstract] [Full Text] [Related]

  • 16. Circulating microparticles and plasma levels of soluble E- and P-selectins in patients with systemic sclerosis.
    Iversen LV, Østergaard O, Ullman S, Nielsen CT, Halberg P, Karlsmark T, Heegaard NH, Jacobsen S.
    Scand J Rheumatol; 2013 Mar 01; 42(6):473-82. PubMed ID: 24016306
    [Abstract] [Full Text] [Related]

  • 17. Natural Killer Cells Contribute to Pathogenesis of Severe Alcoholic Hepatitis by Inducing Lysis of Endothelial Progenitor Cells.
    Sehgal R, Kaur S, Shasthry SM, Agrawal T, Dwivedi V, Seth D, Ramakrishna G, Sarin SK, Trehanpati N.
    Alcohol Clin Exp Res; 2020 Jan 01; 44(1):78-86. PubMed ID: 31746472
    [Abstract] [Full Text] [Related]

  • 18. Brief report: impaired in vivo neovascularization capacity of endothelial progenitor cells in patients with systemic sclerosis.
    Kuwana M, Okazaki Y.
    Arthritis Rheumatol; 2014 May 01; 66(5):1300-5. PubMed ID: 24782187
    [Abstract] [Full Text] [Related]

  • 19. Endogenous PCSK9 may influence circulating CD45neg/CD34bright and CD45neg/CD34bright/CD146neg cells in patients with type 2 diabetes mellitus.
    Tripaldi R, Lanuti P, Simeone PG, Liani R, Bologna G, Ciotti S, Simeone P, Di Castelnuovo A, Marchisio M, Cipollone F, Santilli F.
    Sci Rep; 2021 May 06; 11(1):9659. PubMed ID: 33958634
    [Abstract] [Full Text] [Related]

  • 20. Pattern of endothelial progenitor cells and apoptotic endothelial cell-derived microparticles in chronic heart failure patients with preserved and reduced left ventricular ejection fraction.
    Berezin AE, Kremzer AA, Martovitskaya YV, Berezina TA, Gromenko EA.
    EBioMedicine; 2016 Feb 06; 4():86-94. PubMed ID: 26981573
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.